EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Levels of Myonectin Are Lower in Adults with Metabolic Syndrome and Are Negatively Correlated with Android Fat Mass

Jorge L Petro iD, María Carolina Fragozo-Ramos iD, Andrés F Milán, Juan C Aristizabal iD, Jaime A Gallo-Villegas iD, Juan C Calderón iD

International Journal of Molecular Sciences · 07.04.2023 · 24 (8) · 6874

DOI: 10.3390/ijms24086874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.04.2023. Verfasst von Jorge L Petro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physiology and Biochemistry Research Group-PHYSIS, Faculty of Medicine, University of Antioquia, Medellín 050010, Colombia. Hauptthemen laut MEDLINE: Metabolic Syndrome, Insulin Resistance. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Antioquia, CODI-University of Antioquia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myonectin has shown beneficial effects on lipid regulation in murine models; therefore, it may have implications in the pathophysiology of metabolic syndrome (MS). We evaluated the relationship between serum myonectin and serum lipids, global and regional fat mass, intramuscular lipid content, and insulin resistance (IR) in adults with metabolic risk factors. This was a cross-sectional study in sedentary adults who were diagnosed with MS or without MS (NMS). Serum myonectin was quantified by enzyme-linked immunosorbent assay, lipid profile by conventional techniques, and free fatty acids (FFA) by gas chromatography. Body composition was assessed by dual-energy X-ray absorptiometry and intramuscular lipid content through proton nuclear magnetic resonance spectroscopy in the right vastus lateralis muscle. IR was estimated with the homeostatic model assessment (HOMA-IR). The MS (n = 61) and NMS (n = 29) groups were comparable in age (median (interquartile range): 51.0 (46.0–56.0) vs. 53.0 (45.5–57.5) years, p > 0.05) and sex (70.5% men vs. 72.4% women). MS subjects had lower serum levels of myonectin than NMS subjects (1.08 (0.87–1.35) vs. 1.09 (0.93–4.05) ng·mL−1, p < 0.05). Multiple linear regression models adjusted for age, sex, fat mass index and lean mass index showed that serum myonectin was negatively correlated with the android/gynoid fat mass ratio (R2 = 0.48, p < 0.01), but not with the lipid profile, FFA, intramuscular lipid content or HOMA-IR. In conclusion, serum myonectin is lower in subjects with MS. Myonectin negatively correlates with a component relevant to the pathophysiology of MS, such as the android/gynoid fat mass ratio, but not with other components such as FFA, intramuscular fat or IR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeInsulin ResistanceMaleHumansAdultFemaleAnimalsMiceObesityCross-Sectional StudiesFatty Acids, Nonesterified

Stichwörter der Autor:innen

fatty acidslipid metabolism disorderslipidsmetabolic syndromemyokineskeletal muscle

Substanzen

Fatty Acids, Nonesterified

Autor:innen und Institutionen

  • Physiology and Biochemistry Research Group-PHYSIS, Faculty of Medicine, University of Antioquia, Medellín 050010, Colombia.
  • Research Group in Physical Activity, Sports and Health Sciences-GICAFS, Universidad de Córdoba, Montería 230002, Colombia.
  • Sports Medicine Postgraduate Program, and GRINMADE Research Group, SICOR Center, Faculty of Medicine, University of Antioquia, Medellín 050010, Colombia.

ORCID-Profile: Jorge L Petro, María Carolina Fragozo-Ramos, Juan C Aristizabal, Jaime A Gallo-Villegas, Juan C Calderón

Förderung

  • University of Antioquia
  • CODI-University of Antioquia

Zitieren

APA

Petro, J. L., Fragozo-Ramos, M. C., Milán, A. F., Aristizabal, J. C., Gallo-Villegas, J. A., & Calderón, J. C. (2023). Serum Levels of Myonectin Are Lower in Adults with Metabolic Syndrome and Are Negatively Correlated with Android Fat Mass. International Journal of Molecular Sciences, 24(8), 6874. https://doi.org/10.3390/ijms24086874

Vancouver

Petro JL, Fragozo-Ramos MC, Milán AF, Aristizabal JC, Gallo-Villegas JA, Calderón JC. Serum Levels of Myonectin Are Lower in Adults with Metabolic Syndrome and Are Negatively Correlated with Android Fat Mass. International Journal of Molecular Sciences. 2023;24(8):6874. doi:10.3390/ijms24086874

BibTeX
@article{Petro2023,
  author = {Petro, Jorge L and Fragozo-Ramos, María Carolina and Milán, Andrés F and Aristizabal, Juan C and Gallo-Villegas, Jaime A and Calderón, Juan C},
  title = {Serum Levels of Myonectin Are Lower in Adults with Metabolic Syndrome and Are Negatively Correlated with Android Fat Mass},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {8},
  pages = {6874},
  doi = {10.3390/ijms24086874}
}
Kostenlos starten →